Andrew J. D'Silva insider trades

Open-market stock purchases and sales by Andrew J. D'Silva, Chief Business Officer at OptimizeRx Corp, from SEC Form 4 filings since Aug 21, 2025.

Recent trades

DateStockTradeValue
Dec 19, 2025OPRX OptimizeRx CorpSold (not open market)$9.5K
Dec 11, 2025OPRX OptimizeRx CorpSold (not open market)$12.2K
Oct 3, 2025OPRX OptimizeRx CorpSold (not open market)$14.9K

Companies traded

  • OPRX OptimizeRx Corp: other filings, last Dec 19, 2025

Get free alerts when Andrew J. D'Silva files a new trade →